Methamphetamine Associated Pulmonary Arterial Hypertension: Education, Awareness, and Dialogue 

Program / Course Description 

This program addresses the lack of awareness of methamphetamine associated pulmonary arterial hypertension (METH-PAH), including its epidemiology, clinical characteristics, and known pathophysiology; improving early detection, screening, and diagnosis of METH-PAH; and integrating approaches to the treatment of METH-PAH that seek to address both the PAH and underlying substance use disorder.  

Target Audience

This educational activity is designed for pulmonary specialists, including physicians, nurse practitioners, and physician associates, as well as other health care professionals involved in managing patients with METH-PAH, such as addiction medicine specialists.  

Learning Objectives

Upon completion of this course, the learners should be able to: 

  • Describe the epidemiology and clinical characteristics of METH-PAH   
  • Explain the current understanding of the pathophysiological mechanisms linking methamphetamine use to PAH development   
  • Identify key screening and diagnostic approaches for early detection of PAH in methamphetamine users   
  • Summarize a comprehensive approach to the treatment of METH-PAH that seeks to integrate pharmacotherapy for PAH and substance use disorder management   

Copyright Information

Copyright © 2025 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:  

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.  
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission. 

Commercial Support Acknowledgment

Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The American Thoracic Society designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
Publication Date: 
07/02/2025
Credit Expires: 
07/01/2026
Rating: 
0

Planning Committee

Vinicio de Jesus Perez, MD
Associate Dean of Stanford MD Admissions and Professor of Medicine (PACCM) Stanford Medicine
Palo Alto, CA

Disclosures

Halo| Consultant Stanford School of Medicine | Employment

Steven Shoptaw, PhD
George F Kneller Term Chair in Family Medicine
Vice Chair of Research and Professor in Family Medicine
David Geffen School of Medicine University of California, Los Angeles

Disclosures

Clear Scientific | Consultant
Alkermes, Inc., Gilead Sciences, Indivior | Grant/Contract

Julio Meza, MD
Health Sciences Assistant Clinical Professor Dept. Family Medicine
Addiction Medicine Fellowship Program Director
David Geffen School of Medicine
University of California, Los Angeles

Disclosures

Nothing to disclose

Melissa Glasner
Manager, Medical Content
The France Foundation
Old Lyme, CT

Disclosures

Nothing to disclose

Amanda Noe
Senior Manager, Medical Education and Client Services
The France Foundation
Old Lyme, CT

Disclosures

Nothing to disclose

Emily Perkins
Project Manager
The France Foundation
Old Lyme, CT

Disclosures

Nothing to disclose

Patrick Harty, PhD
Medical Director
The France Foundation
Old Lyme, CT

Disclosures

Nothing to disclose

Jennifer Siegel-Gasiewski, MPA
Director of Lifelong Learning
American Thoracic Society
New York, NY

Disclosures

Nothing to disclose

Content Reviewer

Patrick Harty, PhD
Medical Director
The France Foundation
Old Lyme, CT

Disclosures

Nothing to disclose

It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)

All relevant financial relationships listed have been mitigated
 

Discloser List CME Internal Report

Accredited Provider

This physician activity is provided by the American Thoracic Society. 

This nurse and PA activity is provided by The France Foundation.  

American Thoracic Society - AMA Credits

Physicians 

The American Thoracic Society (ATS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

Physician Credit Designation

The American Thoracic Society designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

The France Foundation - ANCC and AAPA Credits

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

 

Nurses

The France Foundation designates this activity for 1.0 contact hours.

 

Physician Assistants

The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 8/31/2026. PAs should only claim credit commensurate with the extent of their participation.

All other healthcare professionals completing this course will be issued a statement of participation. 

Disclosure Policy

It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education.  The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org) 

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated. 

Disclosure of Unlabeled Use: 

ATS and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ATS and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.  

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    The American Thoracic Society designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
Please login or register to take this course.

If you are requesting AMA credits or a certificate of participation, your certificate will be available for download.

CME Certificates of credit/attendance will be awarded based on the participant attending the activity, completing and submitting an evaluation and attesting to the credits earned. A CME certificate will be available upon successful completion. 
All other healthcare professionals completing this course will be issued a certificate of participation.

The system keeps track of your progress. If you close the activity and resume it later, it will re-start where you left off.

Required Hardware/software

This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers.

Additionally, this site and its activities are best viewed using the latest Operating System for your device.